Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
EUR 117,33
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. In.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 156,24
Anzahl: 2 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 294 pages. 9.25x6.10x0.83 inches. In Stock.
Zustand: New.
Sprache: Englisch
Verlag: Springer International Publishing, 2019
ISBN 10: 3030052214 ISBN 13: 9783030052218
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of 'de-risking' that can be done with preclinical experimentation. This book is essential reading forscientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.
Sprache: Englisch
Verlag: Springer International Publishing, 2019
ISBN 10: 3030052214 ISBN 13: 9783030052218
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Gebundene Ausgabe. Zustand: Sehr gut. Gebraucht - Sehr gut SG - leichte Beschädigungen oder Verschmutzungen, ungelesenes Mängelexemplar, gestempelt, Versand Büchersendung - This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of 'de-risking' that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.